REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 179 filers reported holding REGENXBIO INC in Q2 2018. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,725,743 | -15.3% | 165,598 | +2.9% | 0.00% | – |
| Q2 2023 | $3,218,390 | +144.6% | 161,000 | +131.4% | 0.00% | – |
| Q1 2023 | $1,315,777 | -48.6% | 69,581 | -38.3% | 0.00% | -100.0% |
| Q4 2022 | $2,557,510 | +151.0% | 112,765 | +192.3% | 0.00% | – |
| Q3 2022 | $1,019,000 | -18.2% | 38,573 | -23.5% | 0.00% | -100.0% |
| Q2 2022 | $1,245,000 | -32.8% | 50,425 | -9.7% | 0.00% | 0.0% |
| Q1 2022 | $1,853,000 | -87.9% | 55,819 | -88.1% | 0.00% | -75.0% |
| Q4 2021 | $15,353,000 | -38.0% | 469,491 | -20.5% | 0.00% | -50.0% |
| Q3 2021 | $24,748,000 | +21.4% | 590,359 | +12.5% | 0.01% | +14.3% |
| Q2 2021 | $20,380,000 | +23.4% | 524,569 | +8.4% | 0.01% | +40.0% |
| Q1 2021 | $16,509,000 | -18.0% | 484,004 | +9.0% | 0.01% | -28.6% |
| Q4 2020 | $20,132,000 | +10.4% | 443,837 | -33.0% | 0.01% | 0.0% |
| Q3 2020 | $18,230,000 | +65.0% | 662,412 | +120.8% | 0.01% | +40.0% |
| Q2 2020 | $11,051,000 | -45.4% | 300,038 | -52.0% | 0.01% | -50.0% |
| Q1 2020 | $20,258,000 | -24.5% | 625,625 | -4.5% | 0.01% | +11.1% |
| Q4 2019 | $26,826,000 | +46.7% | 654,776 | +27.4% | 0.01% | +28.6% |
| Q3 2019 | $18,292,000 | +35.3% | 513,797 | +95.3% | 0.01% | +40.0% |
| Q2 2019 | $13,515,000 | +382.7% | 263,094 | +438.6% | 0.01% | +400.0% |
| Q1 2019 | $2,800,000 | -36.9% | 48,850 | -53.8% | 0.00% | -50.0% |
| Q4 2018 | $4,438,000 | -23.2% | 105,786 | +38.2% | 0.00% | 0.0% |
| Q3 2018 | $5,780,000 | +122.1% | 76,550 | +111.1% | 0.00% | +100.0% |
| Q2 2018 | $2,602,000 | +101.5% | 36,257 | -16.2% | 0.00% | 0.0% |
| Q1 2018 | $1,291,000 | +53.7% | 43,251 | +71.2% | 0.00% | – |
| Q4 2017 | $840,000 | -2.9% | 25,257 | -3.7% | 0.00% | – |
| Q3 2017 | $865,000 | +597.6% | 26,238 | +318.3% | 0.00% | – |
| Q2 2017 | $124,000 | +520.0% | 6,272 | +497.3% | 0.00% | – |
| Q1 2017 | $20,000 | -23.1% | 1,050 | -25.4% | 0.00% | – |
| Q4 2016 | $26,000 | +62.5% | 1,407 | +50.0% | 0.00% | – |
| Q4 2015 | $16,000 | -33.3% | 938 | -14.3% | 0.00% | – |
| Q3 2015 | $24,000 | – | 1,094 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |